70 results on '"Musto, Pellegrino"'
Search Results
2. Prognostic relevance of oxidative stress measurement in chronic lymphocytic leukaemia
3. ITACA: A new validated international erythropoietic stimulating agent‐response score that further refines the predictive power of previous scoring systems
4. A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity‐score weighted multicenter approach
5. Lenalidomide and low‐dose dexamethasone (Rd) versus bortezomib, melphalan, prednisone (VMP) in elderly newly diagnosed multiple myeloma patients: A comparison of two prospective trials
6. Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia
7. Novel Agents for the Treatment of Primary Plasma-Cell Leukemia: Lights and Shadows
8. Achievement of European standards by CROB-IRCCS
9. Prospective validation of predictive value of abdominal computed tomography scan on time to first treatment in Rai 0 chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study
10. Supplement to: Autologous Transplantation and Maintenance Therapy in Multiple Myeloma
11. The iron chelator deferasirox affects redox signalling in haematopoietic stem/progenitor cells
12. Darier sign and cutaneous involvement in mastocytosis
13. Autologous Transplantation and Maintenance Therapy in Multiple Myeloma
14. F-18 FDG PET/CT quantization parameters as predictors of outcome in patients with diffuse large B-cell lymphoma
15. Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study
16. MET dysregulation is a hallmark of aggressive disease in multiple myeloma patients
17. Engineering poly(ethylene oxide) buccal films with cyclodextrin: A novel role for an old excipient?
18. Treatment of elderly patients with chronic lymphocytic leukemia: an unmet cinical need
19. Total body computed tomography scan in the initial work-up of Binet stage A chronic lymphocytic leukemia patients: Results of the prospective, multicenter O-CLL1-GISL study
20. Rapid loss of response after withdrawal of treatment with azacitidine: a case series in patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia
21. Cardiovascular Events and Intensity of Treatment in Polycythemia Vera
22. Efficacy and safety of bendamustine for the treatment of patients with recurring Hodgkin lymphoma
23. Genome-wide analysis of primary plasma cell leukemia identifies recurrent imbalances associated with changes in transcriptional profiles
24. A Pilot Characterization of Human Lung NSCLC by Protein Pathway Activation Mapping
25. Fludarabine, cyclophosphamide, and rituximab in patients with advanced, untreated, indolent B-cell nonfollicular lymphomas: Phase 2 study of the Italian Lymphoma Foundation
26. Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome
27. A shorter time to the first treatment may be predicted by the absolute number of regulatory T-cells in patients with Rai stage 0 chronic lymphocytic leukemia
28. Efficacy of bortezomib, lenalidomide and dexamethasone (VRD) in secondary plasma cell leukaemia
29. Extramedullary intracranial localization of multiple myeloma and treatment with novel agents: A retrospective survey of 50 patients
30. Azacitidine for the treatment of patients with acute myeloid leukemia: Report of 82 patients enrolled in an Italian compassionate program
31. An Italian retrospective study on the routine clinical use of low-dose alemtuzumab in relapsed/refractory chronic lymphocytic leukaemia patients
32. An Italian retrospective study on the routine clinical use of low-dose alemtuzumab in relapsed/refractory chronic lymphocytic leukaemia patients
33. Hypomethylating agents for the treatment of acute myeloid leukemia in the elderly
34. BRAF Mutations in Hairy-Cell Leukemia
35. Bendamustine with or without rituximab in the treatment of relapsed chronic lymphocytic leukaemia: an Italian retrospective study
36. Therapeutic approaches for newly diagnosed multiple myeloma patients in the era of novel drugs
37. Azacitidine for the treatment of lower risk myelodysplastic syndromes: A retrospective study of 74 patients enrolled in an Italian named patient program
38. Safety and efficacy of bortezomib-based regimens for multiple myeloma patients with renal impairment: a retrospective study of Italian Myeloma Network GIMEMA
39. Considerations in the treatment of multiple myeloma: a consensus statement from Italian experts
40. High response rate to bortezomib with or without dexamethasone in patients with relapsed or refractory multiple myeloma: results of a global phase 3b expanded access program
41. Clofarabine: in Search of Combinations for the Treatment of Patients With High-Risk Acute Myeloid Leukemia
42. Role of thalidomide in previously untreated patients with multiple myeloma
43. A Multicenter, Randomized Clinical Trial Comparing Zoledronic Acid Versus Observation in Patients With Asymptomatic Myeloma
44. Lenalidomide and its role in the management of multiple myeloma
45. Rituximab for warm-type idiopathic autoimmune hemolytic anemia: a retrospective study of 11 adult patients
46. Two novel imatinib-responsive PDGFRA fusion genes in chronic eosinophilic leukaemia
47. Efficacy and Safety of Bortezomib in Patients With Plasma Cell Leukemia
48. Thalidomide Therapy in Adult Patients With Myelodysplastic Syndrome: A North Central Cancer Treatment Group phase II trial
49. Intermediate-Dose Melphalan (100 mg/m2)/Bortezomib/Thalidomide/Dexamethasone and Stem Cell Support in Patients with Refractory or Relapsed Myeloma
50. Intermediate-Dose Melphalan (100 mg/m2)/Bortezomib/Thalidomide/Dexamethasone and Stem Cell Support in Patients with Refractory or Relapsed Myeloma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.